loading
전일 마감가:
$1.43
열려 있는:
$1.38
하루 거래량:
282.21K
Relative Volume:
1.51
시가총액:
$43.36M
수익:
-
순이익/손실:
$-21.24M
주가수익비율:
-1.6708
EPS:
-0.8379
순현금흐름:
$-22.47M
1주 성능:
-33.96%
1개월 성능:
-44.22%
6개월 성능:
-60.89%
1년 성능:
+0.00%
1일 변동 폭
Value
$1.26
$1.43
1주일 범위
Value
$1.26
$2.25
52주 변동 폭
Value
$1.26
$17.65

Skye Bioscience Inc Stock (SKYE) Company Profile

Name
명칭
Skye Bioscience Inc
Name
전화
(858) 410-0266
Name
주소
11250 EL CAMINO REAL, SUITE 100, SAN DIEGO
Name
직원
16
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
SKYE's Discussions on Twitter

SKYE을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
 icon
SKYE
Skye Bioscience Inc.
3.10 12.89M 0 0 0 0.00
 icon
GOODO
Gladstone Commercial Corporation
20.64 372.90M 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
0.1672 352.85M 2.07B -1.42B -1.37B -0.6765
 icon
MOBBW
Mobilicom Limited Warrants
0.34 278.60M 0 0 0 0.00
 icon
JUNE
Dhandho Junoon Etf
11.05 144.42M 0 0 0 0.00
 icon
SHMD
Schmid Group N V
3.20 137.80M 0 0 0 0.00

Skye Bioscience Inc Stock (SKYE) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-02-28 개시 William Blair Outperform
2024-09-30 개시 Scotiabank Sector Outperform
2024-09-10 개시 JMP Securities Mkt Outperform
2024-07-09 개시 Craig Hallum Buy
2024-05-23 개시 Cantor Fitzgerald Overweight
2024-04-12 개시 Oppenheimer Outperform
모두보기

Skye Bioscience Inc 주식(SKYE)의 최신 뉴스

pulisher
Apr 02, 2025

Charles Schwab Investment Management Inc. Has $176,000 Position in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Charles Schwab Investment Management Inc. Grows Stock Position in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

10,142 Shares in Skye Bioscience, Inc. (NASDAQ:SKYE) Acquired by Virtu Financial LLC - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Virtu Financial LLC Invests $29,000 in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World

Apr 02, 2025
pulisher
Mar 30, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Receives Consensus Rating of “Buy” from Analysts - Defense World

Mar 30, 2025
pulisher
Mar 30, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Receives $18.00 Average Price Target from Analysts - Defense World

Mar 30, 2025
pulisher
Mar 28, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat

Mar 28, 2025
pulisher
Mar 25, 2025

Skye Bioscience, Inc. (PNK:SKYE) Q4 2024 Earnings Call Transcript - MSN

Mar 25, 2025
pulisher
Mar 25, 2025

Skye Bioscience (NASDAQ:SKYE) Receives Outperform Rating from William Blair - MarketBeat

Mar 25, 2025
pulisher
Mar 25, 2025

Skye Bioscience promotes Tu Diep to COO post - The Pharma Letter

Mar 25, 2025
pulisher
Mar 25, 2025

Craig Hallum Issues Pessimistic Forecast for Skye Bioscience (NASDAQ:SKYE) Stock Price - MarketBeat

Mar 25, 2025
pulisher
Mar 24, 2025

Skye Bioscience (NASDAQ:SKYE) Announces Quarterly Earnings Results - MarketBeat

Mar 24, 2025
pulisher
Mar 23, 2025

Skye Bioscience’s SWOT analysis: novel obesity drug stock faces pivotal year - Investing.com Canada

Mar 23, 2025
pulisher
Mar 23, 2025

Skye Bioscience’s (SKYE) “Outperform” Rating Reiterated at William Blair - Defense World

Mar 23, 2025
pulisher
Mar 22, 2025

Skye Bioscience’s SWOT analysis: novel obesity drug stock faces pivotal year By Investing.com - Investing.com South Africa

Mar 22, 2025
pulisher
Mar 22, 2025

SKYE Stock Price and Chart — NASDAQ:SKYE - TradingView

Mar 22, 2025
pulisher
Mar 21, 2025

Skye Bioscience’s Positive Earnings Call Highlights Nimacimab Progress - TipRanks

Mar 21, 2025
pulisher
Mar 21, 2025

Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Skye Bioscience (SKYE) and Bristol-Myers Squibb (BMY) - The Globe and Mail

Mar 21, 2025
pulisher
Mar 21, 2025

Citizens JMP reiterates Skye Bioscience at market outperform By Investing.com - Investing.com Canada

Mar 21, 2025
pulisher
Mar 21, 2025

Citizens JMP reiterates Skye Bioscience at market outperform - Investing.com India

Mar 21, 2025
pulisher
Mar 21, 2025

Skye Bioscience (NASDAQ:SKYE) Shares Down 31% – Time to Sell? - Defense World

Mar 21, 2025
pulisher
Mar 21, 2025

Skye Bioscience (NASDAQ:SKYE) Stock Price Down 31% – Time to Sell? - Defense World

Mar 21, 2025
pulisher
Mar 21, 2025

Skye Bioscience Reports 2024 Financial Results and Trial Progress - TipRanks

Mar 21, 2025
pulisher
Mar 20, 2025

Skye Bioscience accelerates nimacimab clinical trial timeline with early enrollment and extended treatment period - MSN

Mar 20, 2025
pulisher
Mar 20, 2025

Earnings call transcript: Skye Bioscience Q4 2024 highlights financials, product progress - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

Skye Bioscience Inc. (SKYE) reports earnings - Quartz

Mar 20, 2025
pulisher
Mar 20, 2025

Skye Bioscience Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Skye Bioscience Reports Fourth Quarter And Full Year 2024 Financial Results And Provides Business Update - Marketscreener.com

Mar 20, 2025
pulisher
Mar 20, 2025

Skye Bioscience, Inc. SEC 10-K Report - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Skye Bioscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire

Mar 20, 2025
pulisher
Mar 20, 2025

Skye's Obesity Drug Trial Hits Major Milestone with Strong Financial Backing - StockTitan

Mar 20, 2025
pulisher
Mar 18, 2025

Skye Bioscience Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView

Mar 18, 2025
pulisher
Mar 17, 2025

SKYE BIOSCIENCE Earnings Preview: Recent $SKYE Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 17, 2025
pulisher
Mar 14, 2025

Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025 - The Manila Times

Mar 14, 2025
pulisher
Mar 14, 2025

Skye Bioscience to Host Conference Call on March 20, 2025, to Discuss Q4 and Full-Year 2024 Financial Results - Nasdaq

Mar 14, 2025
pulisher
Mar 14, 2025

Skye Bioscience Q4 Earnings: Obesity Treatment Pioneer Reveals 2024 Financial Performance - StockTitan

Mar 14, 2025
pulisher
Mar 05, 2025

Brokerages Set Skye Bioscience, Inc. (NASDAQ:SKYE) Price Target at $18.67 - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Given Average Rating of "Buy" by Analysts - MarketBeat

Mar 04, 2025
pulisher
Mar 04, 2025

Skye Bioscience (NASDAQ:SKYE) Trading Down 2%Should You Sell? - MarketBeat

Mar 04, 2025
pulisher
Mar 04, 2025

Skye Bioscience (NASDAQ:SKYE) Coverage Initiated at William Blair - MarketBeat

Mar 04, 2025
pulisher
Mar 02, 2025

Skye Bioscience (NASDAQ:SKYE) Research Coverage Started at William Blair - Defense World

Mar 02, 2025

Skye Bioscience Inc (SKYE) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
자본화:     |  볼륨(24시간):